About Auxilium Pharmaceuticals
Auxilium Pharmaceuticals is a company based in Philadelphia (United States) founded in 1999 was acquired by Endo International in October 2014.. Auxilium Pharmaceuticals has raised $43 million across 1 funding round from investors including Credit Suisse, Endo International and Schroders. Auxilium Pharmaceuticals has completed 1 acquisition, including Actient Pharma. Auxilium Pharmaceuticals operates in a competitive market with competitors including Agile Therapeutics, Xanodyne Pharmaceuticals, Microchips Biotech, Marius Pharmaceuticals and Asarina Pharma, among others.
- Headquarter Philadelphia, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$43 M (USD)
in 1 rounds
-
Latest Funding Round
$43 M (USD), Series D
Nov 07, 2003
-
Investors
Credit Suisse
& 6 more
-
Employee Count
Employee Count
- Investments & Acquisitions
-
Acquired by
Endo International
(Oct 09, 2014)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Auxilium Pharmaceuticals
Auxilium Pharmaceuticals has successfully raised a total of $43M through 1 strategic funding round. The most recent funding activity was a Series D round of $43 million completed in November 2003. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series D — $43.0M
-
First Round
First Round
(07 Nov 2003)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2003 | Amount | Series D - Auxilium Pharmaceuticals | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Auxilium Pharmaceuticals
Auxilium Pharmaceuticals has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Credit Suisse, Endo International and Schroders. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Auxilium Pharmaceuticals
Auxilium Pharmaceuticals has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Actient Pharma. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Banned-substance-free sports nutrition supplements are manufactured for athletes and bodybuilders.
|
2009 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Auxilium Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Auxilium Pharmaceuticals Comparisons
Competitors of Auxilium Pharmaceuticals
Auxilium Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Agile Therapeutics, Xanodyne Pharmaceuticals, Microchips Biotech, Marius Pharmaceuticals and Asarina Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for women's healthcare are developed and offered.
|
|
| domain | founded_year | HQ Location |
Developer of drugs for women's health and pain management
|
|
| domain | founded_year | HQ Location |
Microchip implants for wireless drug delivery are developed.
|
|
| domain | founded_year | HQ Location |
A proprietary oral testosterone replacement therapy platform is developed.
|
|
| domain | founded_year | HQ Location |
Pharmaceuticals for PMDD, migraine, and Tourette syndrome are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Auxilium Pharmaceuticals
Frequently Asked Questions about Auxilium Pharmaceuticals
When was Auxilium Pharmaceuticals founded?
Auxilium Pharmaceuticals was founded in 1999 and raised its 1st funding round 4 years after it was founded.
Where is Auxilium Pharmaceuticals located?
Auxilium Pharmaceuticals is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
Is Auxilium Pharmaceuticals a funded company?
Auxilium Pharmaceuticals is a funded company, having raised a total of $43M across 1 funding round to date. The company's 1st funding round was a Series D of $43M, raised on Nov 07, 2003.
What does Auxilium Pharmaceuticals do?
Auxilium Pharmaceuticals was founded in 1999 and is based in Philadelphia, United States. Therapeutics and drug-device combinations are developed by the company for urology and sexual health, including treatments for hypogonadism (Testim), testosterone replacement (Testopel, Striant), and erectile dysfunction (Edex, Osbon ErecAid, Stendra). Additional development efforts have been directed toward therapies for respiratory diseases and rare disorders within the pharmaceutical sector.
Who are the top competitors of Auxilium Pharmaceuticals?
Auxilium Pharmaceuticals's top competitors include Agile Therapeutics, Marius Pharmaceuticals and Peptonic Medical.
How many acquisitions has Auxilium Pharmaceuticals made?
Auxilium Pharmaceuticals has made 1 acquisition, including Actient Pharma.
Who are Auxilium Pharmaceuticals's investors?
Auxilium Pharmaceuticals has 7 investors. Key investors include Credit Suisse, Endo International, Schroders, Orbimed, and BB Biotech Ventures.